About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
Cervical cancer is a global public health subject as it affects women in the reproductive ages, and accounts for the second largest burden among cancer patients worldwide with an unforgiving 50% morta. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "initial_mi_r",
"label": "MiR",
"units": "native SBML value",
"default": 1.2e-7,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_mi_r",
"description": "Initial MiR. Sets the initial value of bundled SBML symbol `miR`."
},
{
"name": "initial_antimi_r",
"label": "AntimiR",
"units": "native SBML value",
"default": 1.2e-7,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_antimi_r",
"description": "Initial AntimiR. Sets the initial value of bundled SBML symbol `antimiR`."
},
{
"name": "initial_toehold_dna",
"label": "Toehold DNA",
"units": "native SBML value",
"default": 2.35e-7,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_toehold_dna",
"description": "Initial Toehold DNA. Sets the initial value of bundled SBML symbol `Toehold_DNA`."
},
{
"name": "initial_gfp",
"label": "GFP",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_gfp",
"description": "Initial GFP. Sets the initial value of bundled SBML symbol `GFP`."
},
{
"name": "initial_toehold_rna_cts",
"label": "Toehold RNA CTS",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_toehold_rna_cts",
"description": "Initial Toehold RNA CTS. Sets the initial value of bundled SBML symbol `Toehold_RNA_CTS`."
},
{
"name": "initial_mi_r_antimi_r",
"label": "MiR antimiR",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_mi_r_antimi_r",
"description": "Initial MiR antimiR. Sets the initial value of bundled SBML symbol `miR_antimiR`."
}
],
"outputs": [
{
"name": "mi_r",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.mi_r",
"description": "MiR observable. Maps to SBML symbol `miR`."
},
{
"name": "antimi_r",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.antimi_r",
"description": "AntimiR observable. Maps to SBML symbol `antimiR`."
},
{
"name": "toehold_dna",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.toehold_dna",
"description": "Toehold DNA observable. Maps to SBML symbol `Toehold_DNA`."
},
{
"name": "gfp",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.gfp",
"description": "GFP observable. Maps to SBML symbol `GFP`."
},
{
"name": "toehold_rna_cts",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.toehold_rna_cts",
"description": "Toehold RNA CTS observable. Maps to SBML symbol `Toehold_RNA_CTS`."
},
{
"name": "mi_r_antimi_r",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.mi_r_antimi_r",
"description": "MiR antimiR observable. Maps to SBML symbol `miR_antimiR`."
},
{
"name": "state",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"systemsbiology",
"tumor-growth"
],
"title": "Palaniappan2021 - Cell free modelling of second generation Toehold switches Lab",
"models": [
{
"path": "models/core",
"alias": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model_state"
],
"from": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.state"
},
{
"to": [
"visualisation.oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model_summary"
],
"from": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model_species_labels"
],
"from": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.species_labels"
}
],
"package": "palaniappan2021-cell-free-modelling-of-second-generatio-0624b77b",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "Cervical cancer is a global public health subject as it affects women in the reproductive ages, and accounts for the second largest burden among cancer patients worldwide with an unforgiving 50% morta. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagepalaniappan2021-cell-free-modelling-of-second-generatio-0624b77b
Created2026-05-16
Updated2026-06-13
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsystemsbiologytumor-growthvisualisationother